Medtronic plc Approves Cash Dividend for Fourth Quarter of Fiscal Year 2025

The board of directors of Medtronic plc (NYSE: MDT) in Galway, Ireland, has approved a cash dividend for the fourth quarter of fiscal year 2025. The dividend amount is $0.70 per ordinary share and is payable on April 11, 2025, to shareholders of record as of March 28, 2025. This decision aligns with Medtronic’s commitment to increasing dividends, as demonstrated by its 47-year track record of annual dividend growth.

About Medtronic
Medtronic plc is a global healthcare technology company headquartered in Galway, Ireland. With a mission to alleviate pain, restore health, and extend life, Medtronic’s innovative technologies and therapies address 70 different health conditions. From cardiac devices to patient monitoring systems, Medtronic’s diverse range of products impacts lives worldwide. With a team of over 95,000 employees across 150 countries, Medtronic is dedicated to delivering transformative solutions that empower insight-driven care and prioritize better outcomes for patients.

Forward-Looking Statements
As with any investment, there are risks and uncertainties associated with Medtronic’s business. Investors are encouraged to review Medtronic’s periodic reports filed with the Securities and Exchange Commission to understand potential factors that could impact actual results.

Contact Information
For media inquiries, please contact Erika Winkels at +1-763-526-8478. For investor relations, please reach out to Ryan Weispfenning at +1-763-505-4626.

In conclusion, Medtronic’s approval of a cash dividend for the fourth quarter of fiscal year 2025 reflects the company’s commitment to providing value to its shareholders. With a strong focus on innovative healthcare solutions and a dedication to improving patient outcomes, Medtronic continues to lead the industry in addressing critical health challenges. Stay connected with Medtronic for the latest updates and advancements in healthcare technology.